Wesley Day
Albert Einstein College of Medicine(US)Yale New Haven Hospital(US)Uniformed Services University of the Health Sciences(US)Center for Scientific Review(US)Yale University(US)Konrad-Adenauer-Stiftung(DE)Niramaya Hospital(IN)Niramaya Healthcare(IN)
Publications by Year
Research Areas
Pharmacology and Obesity Treatment, Spine and Intervertebral Disc Pathology, Diabetes Treatment and Management, Sexual function and dysfunction studies, Hormonal and reproductive studies
Most-Cited Works
- → Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial(2011)1,030 cited
- → Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)(2011)707 cited
- → Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study(2011)694 cited
- → Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release(2013)209 cited
- → Cardiovascular effects of phentermine and topiramate(2014)118 cited
- → Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene